Card Title
WHAT IS KYBELLA®?
See our new privacy terms at https://privacy.abbvie/.
Actual patients. Unretouched photos taken before treatment and after final treatment. Not all treatments shown. Individual results may vary.
Multiple injections under the chin per treatment; up to 6 treatments spaced at least 1 month apart. 59% of patients received 6 KYBELLA® treatments in clinical studies. Treatment is tailored to the amount of fat under the chin and aesthetic goals.
68.2% of patients treated with KYBELLA® in 2 clinical studies had some/moderately better improvement, compared with 20.5% of patients treated with placebo (70% vs 18.6% in Study 1, 66.5% vs 22.2% in Study 2).
16% of patients treated with KYBELLA® in 2 clinical studies had significant/a great deal better improvement, compared with 2% of patients treated with placebo (13.4% vs less than 0% in Study 1, 18.6% vs 3% in Study 2).
VISIBLE RESULTS
IN 2-4 TREATMENTS
MANY PATIENTS EXPERIENCE VISIBLE RESULTS AFTER 2 TO 4 TREATMENTS. 59% OF PATIENTS RECEIVED 6 TREATMENTS IN CLINICAL TRIALS.
COMBINED PHYSICIAN AND PATIENT RATING FOR LEVEL OF IMPROVEMENT
12 WEEKS AFTER FINAL TREATMENT
TRIAL 1 | TRIAL 2 | |||
---|---|---|---|---|
ENDPOINT | KYBELLA® (N = 256) | PLACEBO (N = 250) | KYBELLA® (N = 258) | PLACEBO (N = 258) |
Significant/ a great deal better (2-grade composite response)a | 13.4% | <0.01% | 18.6% | 3.0% |
Some/ moderately better (1-grade composite response)b | 70% | 18.6% | 66.5% | 22.2% |
TREATMENT DETAILS | AFTER 1 TREATMENT | AFTER 2 TREATMENTS | AFTER 3 TREATMENTS | AFTER 4 TREATMENTS | AFTER 5 TREATMENTS | AFTER 6 TREATMENTS | |
---|---|---|---|---|---|---|---|
Percentage of patients who experienced some improvement (moderately better) | KYBELLA | 8% | 28% | 43% | 55% | 66% | 72% |
PLACEBO | 2% | 7% | 12% | 14% | 15% | 22% | |
Percentage of patients who experienced significant improvement (a great deal better) | KYBELLA | 0% | 0% | 1% | 4% | 4% | 15% |
PLACEBO | 0% | 0% | 0% | 1% | 0% | 2% |
a At least 2-grade reduction on both the clinician-reported and patient-reported ratings of submental fat.
b At least 1-grade reduction on both the clinician-reported and patient-reported ratings of submental fat.
I inherited my double chin from my family. I was so frustrated because it felt out of my control.
Jason, 36
I used to be a little heavier and my double chin was really obvious. But even after I lost the weight, it was still there.
Adra, 36
I’m used to getting aesthetic treatments, but I’m not willing to go under the knife. So KYBELLA® was the right choice for me.
Nikki, 35
The fact that KYBELLA® is an injectable treatment was a big plus, and I liked that treatment was tailored to me by my doctor.
David, 54
"I inherited my double chin from my family. I was so frustrated because it felt out of my control."
Jason, 36
"I used to be a little heavier and my double chin was really obvious. But even after I lost the weight, it was still there.”
Adra, 36
“I’m used to getting aesthetic treatments, but I’m not willing to go under the knife. So KYBELLA® was the right choice for me.”
Nikki, 35
"The fact that KYBELLA® is an injectable treatment was a big plus, and I liked that treatment was tailored to me by my doctor."
David, 54
IN CLINICAL STUDIES,
79%
OF PATIENTS TREATED WITH KYBELLA® HAD IMPROVED SATISFACTION WITH THE APPEARANCE OF THEIR FACE AND AREA BENEATH THEIR CHIN 12 WEEKS AFTER LAST TREATMENT, COMPARED WITH 33.6% OF PATIENTS TREATED WITH PLACEBO.
More than 1600 people worldwide have been treated in clinical studies with KYBELLA® as part of a global clinical development program.
WHAT IS KYBELLA®?
APPROVED USE AND IMPORTANT SAFETY INFORMATION
What is KYBELLA®?
KYBELLA® is a prescription medicine used in adults to improve the appearance and profile of moderate to severe fat below the chin (submental fat), also called “double chin.”
It is not known if KYBELLA® is safe and effective for the treatment of fat outside of the submental area or in children under 18 years of age.
Who should not receive KYBELLA®?
Do not receive KYBELLA® if you have an infection in the treatment area.
Before receiving KYBELLA®, tell your healthcare provider about all of your medical conditions, including if you have had or plan to have surgery on your face, neck, or chin; have had cosmetic treatments on your face, neck, or chin; have had or have medical conditions in or near the neck area; have had or have trouble swallowing; have bleeding problems; are pregnant or plan to become pregnant (it is not known if KYBELLA® will harm your unborn baby); are breastfeeding or plan to breastfeed (it is not known if KYBELLA® passes into your breast milk).
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Especially tell your healthcare provider if you take a medicine that prevents the clotting of your blood (antiplatelet or anticoagulant medicine).
What are the possible side effects of KYBELLA®?
KYBELLA® can cause serious side effects, including:
The most common side effects of KYBELLA® include swelling, pain, numbness, redness, and areas of hardness in the treatment area.
These are not all of the possible side effects of KYBELLA®. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/safety/MedWatch or call 1-800-FDA-1088.
Please see KYBELLA® full Prescribing Information.
Please see accompanying full Prescribing Information, or ask your healthcare provider, or visit MyKybella.com.